Concepedia

Yefen Zou

YZ

Statistics

Publications

3

Citations

106

H-Index

3

Active since

2019

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Yefen Zou is an author at Genomics Institute of the Novartis Research Foundation specializing in drug discovery, diabetes mellitus, and medicinal chemistry.

Publications per year

2019–2020

3

Publications

3

Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133

Yahu A. Liu, Qihui Jin, Yefen Zou et al. · Journal of Medicinal Chemistry · 2020 · 77 citations · Full text

, , +15

A Dual Inhibitor of DYRK1A and GSK3β for β‐Cell Proliferation: Aminopyrazine Derivative GNF4877

Yahu A. Liu, Qihui Jin, Qiang Ding et al. · ChemMedChem · 2020 · 17 citations

, , +17

Discovery of 5-(3,4-Difluorophenyl)-3-(pyrazol-4-yl)-7-azaindole (GNF3809) for β-Cell Survival in Type 1 Diabetes

Zhihong Huang, Matthew S. Tremblay, Tom Wu et al. · ACS Omega · 2019 · 12 citations · Full text

, , +17

1–3 of 3